Epidural Nalbuphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries
Status:
Recruiting
Trial end date:
2022-01-15
Target enrollment:
Participant gender:
Summary
Combined spinal epidural anesthesia (CSE) with bupivacaine alone is not sufficient to cover
pain sequel during lower limb surgeries.
Previous studies used addition of either Nalbuphine or dexmedetomidine to bupivacaine in
epidural anesthesia giving a good result in pain control.
In this study the investigators will evaluate and compare the addition of either Nalbuphine
or dexmedetomidine to bupivacaine in epidural anesthesia to evaluate the analgesic efficacy
of either drug.